3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
16
Carcinoma, Non-Small-Cell Lung
7
Ovarian Neoplasms
5
Uterine Cervical Neoplasms
4
Stomach Neoplasms
3
Neoplasms
3
Lung Neoplasms
3
Endometrial Neoplasms
3
Triple Negative Breast Neoplasms
2
Pancreatic Intraductal Neoplasms
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Thrombosis
1
Stage IA Uterine Sarcoma
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumors
1
Solid Tumor Cancer
1
Sarcoma
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Peripheral Nervous System Diseases
1
Pancreatic Cyst
1
Pain
1
Organoid
1
Neoplasms, Germ Cell and Embryonal
1
NSCLC
1
Motor Activity
1
Medulloblastoma
1
Malignant Airway Obstruction Secondary to Non-small Cell Lung Cancer
1
Interventions
Exercise
2
pyrotinib
1
palbociclib
1
Trastuzumab
1
Tomography, X-Ray Computed
1
Surveys and Questionnaires
1
Surgimend
1
Paclitaxel
1
Mammaplasty
1
Liquid Biopsy
1
Fentanyl
1
Epirubicin
1
Educational Status
1
Docetaxel
1
Cyclophosphamide
1
Cryotherapy
1
Cholecalciferol
1
Carboplatin
1
Bupivacaine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Breast Diseases
×
Paclitaxel
×
Clear all
NCT03756090
2018-12-07
PECP
Zhejiang Cancer Hospital
Phase NA
Unknown
100 enrolled